Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F.

Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. English, Spanish.

PMID:
22609214
2.

Can we predict stroke in atrial fibrillation?

Lip GY.

Clin Cardiol. 2012 Jan;35 Suppl 1:21-7. doi: 10.1002/clc.20969. Review.

3.

CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.

Naccarelli GV, Panaccio MP, Cummins G, Tu N.

Am J Cardiol. 2012 May 15;109(10):1526-33. doi: 10.1016/j.amjcard.2012.01.371. Review.

PMID:
22360819
4.

Improving stroke risk stratification in atrial fibrillation.

Lip GY, Halperin JL.

Am J Med. 2010 Jun;123(6):484-8. doi: 10.1016/j.amjmed.2009.12.013. Review.

PMID:
20569748
5.
6.

[Atrial fibrillation and stroke].

Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1453-7. doi: 10.4045/tidsskr.12.0850. Review. Norwegian.

7.

[Anticoagulation in atrial fibrillation. Strategies in special situations].

Volkmann H, Walter M, Walter C, Vetter S.

Clin Res Cardiol Suppl. 2011 May;6:58-65. Review. German.

PMID:
22528179
8.

Bleeding risk assessment in patients with atrial fibrillation who are taking oral anticoagulants.

Guo Y, Lip GY, Apostolakis S.

Hosp Pract (1995). 2013 Feb;41(1):71-8. doi: 10.3810/hp.2013.02.1012. Review.

PMID:
23466969
9.

The CHADS₂versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use.

Odum LE, Cochran KA, Aistrope DS, Snella KA.

Pharmacotherapy. 2012 Mar;32(3):285-96. doi: 10.1002/j.1875-9114.2012.01023.x. Review.

PMID:
22392459
10.

Atrial fibrillation: established and innovative methods of evaluation and treatment.

Trappe HJ.

Dtsch Arztebl Int. 2012 Jan;109(1-2):1-7. doi: 10.3238/arztebl.2012.0001. Review.

11.

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.

Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane DA, Levi M, Marin F, Palareti G, Kirchhof P; Document reviewers:., Collet JP, Rubboli A, Poli D, Camm J.

Europace. 2011 May;13(5):723-46. doi: 10.1093/europace/eur126.

PMID:
21515596
12.

[Antithrombotic management in atrial fibrillation].

Fauchier L, Taillandier S, Clementy N.

Rev Prat. 2013 Feb;63(2):199, 201-6. Review. French. Erratum in: Rev Prat. 2013 Mar;63(3):330.

PMID:
23513780
13.

Stroke and thromboembolism in atrial fibrillation.

Pisters R, Lane DA, Marin F, Camm AJ, Lip GY.

Circ J. 2012;76(10):2289-304. Review.

14.

[Clinical risk stratification schemes to predict thromboembolism in patients with atrial fibrillation].

Hirai T, Inoue H.

Nihon Rinsho. 2013 Jan;71(1):105-11. Review. Japanese.

PMID:
23631180
15.

Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question!".

Patti G, Cavallari I.

Heart Rhythm. 2015 Dec;12(12):2515-20. doi: 10.1016/j.hrthm.2015.07.017. Review.

PMID:
26188249
16.

Managing anticoagulation for atrial fibrillation: current issues and future strategies.

John Camm A.

J Intern Med. 2013 Jan;273(1):31-41. doi: 10.1111/joim.12001. Review.

17.

Stroke and bleeding risk in atrial fibrillation.

Senoo K, Lane D, Lip GY.

Korean Circ J. 2014 Sep;44(5):281-90. doi: 10.4070/kcj.2014.44.5.281. Review.

18.

A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation.

Lip GY, Potpara T, Boriani G, Blomström-Lundqvist C.

J Intern Med. 2016 May;279(5):467-76. doi: 10.1111/joim.12468. Review.

PMID:
27001354
19.

Thromboembolism in patients with nonvalvular atrial fibrillation: comparison between Asian and Western countries.

Inoue H.

J Cardiol. 2013 Jan;61(1):1-7. doi: 10.1016/j.jjcc.2012.08.012. Review.

20.

[Thromboembolic and bleeding risk assessment in patients with non-rheumatic atrial fibrillation using CHA2DS2-VASc and HAS-BLED scoring systems].

Bozić I, Cvitković I, Carević V, Caljkusić K, Trgo G, Fabijanić D.

Lijec Vjesn. 2013 Mar-Apr;135(3-4):86-91. Review. Croatian.

PMID:
23671975
Items per page

Supplemental Content

Support Center